Graft Survival With Urological Complications

Introduction:

The most effective treatment for chronic kidney disease (CKD) is kidney transplantation (KT), which significantly positively influences the quality of life. Patients with type 2 kidney transplants have immunosuppression and may be more prone to fragility due to comorbidities from long-standing chronic kidney disease. Major urologic complications (MUCs) are the second leading cause of morbidity after kidney transplant and can result in graft loss and death. The total prevalence varies from 3.4 to 11.2 percent. A urine leak, ureteral stenosis, ureteral stricture, bladder outlet obstruction (BOO), symptomatic vesicoureteral reflux (VUR), and graft lithiasis are all MUCs. Urinary leaks are the most prevalent kind of MUC. Complications are frequently classified as either early or late. MUCs were associated with longer hospital stays, greater overall costs per patient, and the need for further treatments. They can appear at any moment after transplantation and have an excellent prognosis if diagnosed and treated promptly. MUCs are most commonly found at the ureterovesical anastomosis.

What Are the Risk Factors?

• Several studies have sought to identify risk variables related to the development of urologic problems. Some studies have revealed that transplantation from a liver donor and stenting of the vesicoureteral anastomosis are independent variables linked with a lower incidence of urinary problems.

• Male gender, delayed graft function, donor age over 65, repeat transplant, obesity, numerous donor arteries, and extensive removal of fat from the donor ureter have all been linked to greater incidence of overall urologic problems.

• Atrophic bladders have also been linked to an increased risk of urological problems. Furthermore, post-transplant diagnosis of benign prostatic hypertrophy has been linked to an increase in post-transplant urine outflow obstructive problems.

What Are the Various Complications?

Complications for Ureteroneocystostomy:

• The two most common techniques for ureteroneocystostomy are refluxing (full thickness) and anti-refluxing (Lich-Gregoir). Recent data from 600 patients investigated the urologic problems associated with each type of anastomosis.

• Both groups were comparable in terms of complication rates, graft and patient survival, duration of stay, and prevalence of urinary tract infections within the initial year following the transplant.

Complications for Ureteral Stents:

• The choice of ureteral stents during kidney transplantation differs according to center and surgeon choices, and their effectiveness in reducing urologic complications remains debatable.

• Recent research of above 700 patients discovered that individuals who were stented at the time of transplant had a lower frequency of ureteral stenosis and fistula (abnormal connections between two body parts). Still, there was a high prevalence of urinary tract infections.

• The timeframe for the removal of the ureteral stent postoperatively is also debatable. However, it may impact the occurrence of urinary tract infections. A new prospective, randomized, double-blind trial of 103 patients investigated the differences in ureteral stent removal at one and four weeks after surgery.

• Early ureteral stent removal at one week postoperatively decreased the incidence of urinary tract infection with no changes in mechanical problems between the two groups, indicating that stent removal at the early stage may safely reduce UTIs without increasing other urologic complications.

What Is the Diagnosis?

• Recognizing and diagnosing urologic problems as soon as possible is essential for maintaining graft function. Hydronephrosis, with or without graft malfunction, is frequently the first indicator of a urologic problem.

• When assessing, it is critical to describe renal allograft urinary obstruction using active investigations and to rule out more indolent disorders such as asymptomatic VUR. When patients experience new-onset hydronephrosis and decreasing transplant function without any recognized factors, there should be more concern for pathologic blockage.

• The initial examination usually includes renal transplant sonography and the estimation of a post-void residual. Further testing may involve diuretic nuclear renography or antegrade pyelography, allowing prompt urine diversion if a blockage is found. Once validated, the barrier should be characterized as either extrinsic or intrinsic.

• Ureteral stenosis is the most prevalent post-transplant problem resulting in hydronephrosis, necessitating surgical surgery. Sonography of the pelvis, computed tomography imaging, or fluid aspiration can identify extrinsic causes such as lymphocele or hematoma. Except for radiopaque ureteral calculi, the reasons for intrinsic blockage might be obscure and need further evaluation.

What Is Ureteral Obstruction Due to Transplantation?

• The causes of ureteral obstruction related to stenosis vary, with a frequency ranging from 1 to 6.5 percent. Ischemia is the most commonly recognized cause of post-transplant ureteral stenosis. Preserving the donor allograft's lower pole auxiliary arteries and periureteral tissue is critical in preventing ischemia insulting the ureter.

• Recurrent infection and rejection are the most common causes of delayed ureteral stenosis. Occasionally, obstruction from the ureteral stone or blood clot must be distinguished from luminal stenosis.

• Initially, on sonography, ureteral stenosis may manifest as new-onset or worsening hydronephrosis (a condition in which urine accumulates in the kidneys). This may or may not be related to decreasing urine output and glomerular filtration rate.

• Percutaneous antegrade pyelography and nephrostomy (an artificial opening created between the kidneys and the skin) tube implantation can further evaluate and treat ureteral stenosis.

• Before inserting a nephrostomy tube, a Whitaker test can be utilized to confirm blockage. Other diagnostic methods include voiding cystourethrography(procedure to evaluate female urethra), renography, and retrograde pyelography (X-ray examination of the urinary tract) in a refluxing system.

• The treatment of allograft ureteral stenosis is mostly determined by patient circumstances and clinician choice. Because surgical repair offers more permanent therapy, open repair is often considered the gold standard for ureteral stenosis.

• The transplant surgeon would normally use several procedures depending on the location and duration of the stricture. Techniques reported comprise ureteroneocystostomy (reimplantation of the ureter into the bladder), ureteropyelostomy, vesicopyelostomy, and interposition of the small bowel with or without the use of a boari flap or psoas hitch.

• Chronic ureteral stenting, percutaneous transplant nephrostomy tube implantation, or subcutaneous pyelovesical bypass graft installation are third-line therapy choices for ureteral stenosis.

• These procedures are often intended for individuals who have failed open surgical repair, are too risky for open surgery, or have intractable ureteral strictures despite endoscopic therapy.

• Long-term stenting or diversion is not recommended in immunocompromised patients because of the increased likelihood of recurrent urine infection and graft degradation.

What Is Ureteral Obstruction Due to Urinary Fistulas?

• Urine leaks manifest in various ways, but they most typically occur at the ureterovesical anastomosis and frequently necessitate re-operation. Most of them are linked to ischemic necrosis of the ureter, which causes poor anastomotic repair during the first month after transplant.

• Improper bladder healing in the presence of a defunctionalized bladder, premature removal of ureteral or bladder drainage, technical mistakes, increased bladder pressure from urine retention, or structural perforation during ureteral stent implantation are the less common causes of fistula development.

• Clinical signs such as reduced urine output, abdominal distension, or a sudden rise in surgical drain output with fluid creatinine test evidence might be used to diagnose.

Conclusion:

Urologic problems are prevalent after a kidney transplant. It is critical to be familiar with the problems associated with the complications since urologists should possess unique skill sets that are specific to managing these complications and critical to the multidisciplinary care of these patients.